Latest News
- Min. Nadda Unveils ?13,000-Crore Bio-Pharma SHAKTI and Chemical Parks Push to Expand India’s Global Chemicals and Biologics Footprint
- Aurobindo Pharma Subsidiary Launches Generic Cancer Drug in US, Expands Oncology Portfolio in Global Generics Market
- KIMS Hospitals Introduces Adaptive Deep Brain Stimulation in India for Advanced Parkinson’s Treatment
Torrent Pharma’s market cap crosses $10bn mark
- By TNN
- Ahmedabad
- Jan 12, 2024
Ahmedabad-based Torrent Pharmaceuticals Ltd has crossed the $10 billion market capitalisation mark as its stock price rose 4.93 per cent on Thursday to close at Rs 2,468.95 on NSE. Torrent Pharma’s market cap is now at Rs 83,560 crore (US$ 10.06 billion).
Torrent Pharma is ranked amongst the top leaders in the therapeutic segments of cardiovascular, central nervous system, gastrointestinal and women healthcare. It also has a significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments.
Gunjan Choksi, a city-based analyst, said, “Torrent Pharmaceuticals has crossed the milestone of $10 billion market capitalisation mark. It has registered consistent growth and strong financial performance. In the last three months, the stock has registered an increase of 30.94 per cent. It posted revenue of more than Rs 9,400 crore in FY2023 and investors believe the company's double-digit growth will continue due to its strong presence and products.”